Nasir Idkaidek

1.1k total citations
70 papers, 840 citations indexed

About

Nasir Idkaidek is a scholar working on Pharmacology, Pharmacology and Pharmaceutical Science. According to data from OpenAlex, Nasir Idkaidek has authored 70 papers receiving a total of 840 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pharmacology, 17 papers in Pharmacology and 15 papers in Pharmaceutical Science. Recurrent topics in Nasir Idkaidek's work include Pharmacogenetics and Drug Metabolism (13 papers), Analytical Methods in Pharmaceuticals (11 papers) and Antibiotics Pharmacokinetics and Efficacy (11 papers). Nasir Idkaidek is often cited by papers focused on Pharmacogenetics and Drug Metabolism (13 papers), Analytical Methods in Pharmaceuticals (11 papers) and Antibiotics Pharmacokinetics and Efficacy (11 papers). Nasir Idkaidek collaborates with scholars based in Jordan, United States and United Arab Emirates. Nasir Idkaidek's co-authors include Tawfiq Arafat, Naji M. Najib, Ehab A. Abu‐Basha, Isra Dmour, Ruwayda Dham, Faisal Al-Akayleh, Mayyas Al‐Remawi, Nidal A. Qinna, Gordon L. Amidon and Mai Khanfar and has published in prestigious journals such as Pharmaceutical Research, Journal of Molecular Liquids and European Journal of Pharmaceutics and Biopharmaceutics.

In The Last Decade

Nasir Idkaidek

66 papers receiving 806 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nasir Idkaidek Jordan 17 213 174 134 123 111 70 840
Arzu Selen United States 18 200 0.9× 253 1.5× 238 1.8× 81 0.7× 162 1.5× 30 931
André J. Jackson United States 19 106 0.5× 165 0.9× 142 1.1× 122 1.0× 102 0.9× 46 800
KD Tripathi India 8 163 0.8× 195 1.1× 86 0.6× 153 1.2× 43 0.4× 26 1.3k
Hwi‐yeol Yun South Korea 17 69 0.3× 136 0.8× 182 1.4× 129 1.0× 154 1.4× 107 925
Noriyuki Namiki Japan 16 208 1.0× 69 0.4× 113 0.8× 118 1.0× 68 0.6× 70 713
Cristina Helena dos Reis Serra Brazil 18 174 0.8× 83 0.5× 62 0.5× 51 0.4× 74 0.7× 55 983
W. Tetzloff Germany 10 203 1.0× 96 0.6× 165 1.2× 63 0.5× 99 0.9× 13 659
Oliver Yoa‐Pu Hu Taiwan 24 330 1.5× 176 1.0× 138 1.0× 355 2.9× 195 1.8× 86 1.7k
H Laufen Germany 22 103 0.5× 325 1.9× 104 0.8× 176 1.4× 186 1.7× 76 1.5k
Quan Zhou China 16 53 0.2× 110 0.6× 89 0.7× 127 1.0× 93 0.8× 37 857

Countries citing papers authored by Nasir Idkaidek

Since Specialization
Citations

This map shows the geographic impact of Nasir Idkaidek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nasir Idkaidek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nasir Idkaidek more than expected).

Fields of papers citing papers by Nasir Idkaidek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nasir Idkaidek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nasir Idkaidek. The network helps show where Nasir Idkaidek may publish in the future.

Co-authorship network of co-authors of Nasir Idkaidek

This figure shows the co-authorship network connecting the top 25 collaborators of Nasir Idkaidek. A scholar is included among the top collaborators of Nasir Idkaidek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nasir Idkaidek. Nasir Idkaidek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Hawari, Feras, et al.. (2023). Safety, Tolerability, and Pharmacokinetics of Nebulized Hydroxychloroquine: A Pilot Study in Healthy Volunteers. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 36(2). 76–81. 1 indexed citations
4.
Abu‐Basha, Ehab A., et al.. (2023). Comparison of pharmacokinetics of two tylvalosin oral formulations in broiler chickens. Journal of Veterinary Pharmacology and Therapeutics. 46(3). 165–169. 1 indexed citations
5.
6.
Alzoughool, Foad, et al.. (2022). Impact of Sustained Exogenous Irisin Myokine Administration on Muscle and Myocyte Integrity in Sprague Dawley Rats. Metabolites. 12(10). 939–939. 3 indexed citations
7.
Alzoughool, Foad, et al.. (2022). The Role of Interventional Irisin on Heart Molecular Physiology. Pharmaceuticals. 15(7). 863–863. 5 indexed citations
8.
Al-Akayleh, Faisal, et al.. (2020). A Novel Eutectic-Based Transdermal Delivery System for Risperidone. AAPS PharmSciTech. 22(1). 4–4. 46 indexed citations
9.
10.
11.
12.
Qinna, Nidal A., et al.. (2017). Glucosamine modulates propranolol pharmacokinetics via intestinal permeability in rats. European Journal of Pharmaceutical Sciences. 105. 137–143. 12 indexed citations
13.
Mallah, Eyad, et al.. (2011). Plasma concentrations of 25-hydroxyvitamin D among Jordanians: Effect of biological and habitual factors on vitamin D status. BMC Clinical Pathology. 11(1). 8–8. 40 indexed citations
14.
Salem, Isam I., Naji M. Najib, & Nasir Idkaidek. (2010). A retrospective, open-label analysis of the population pharmacokinetics of a single 10-mg dose of loratadine in healthy white Jordanian male volunteers. Clinical Therapeutics. 32(2). 391–395. 4 indexed citations
15.
Abu‐Basha, Ehab A., et al.. (2007). Pharmacokinetics of Tilmicosin (Provitil Powder and Pulmotil Liquid AC) Oral Formulations in Chickens. Veterinary Research Communications. 31(4). 477–485. 40 indexed citations
16.
Najib, Naji M., et al.. (2004). Comparative bioavailability of two brands of atenolol 100 mg tablets (Tensotin and Tenormin) in healthy human volunteers. Biopharmaceutics & Drug Disposition. 26(1). 1–5. 6 indexed citations
17.
Idkaidek, Nasir, et al.. (2004). Bioequivalence evaluation of two brands of amoxicillin/clavulanic acid 250/125 mg combination tablets in healthy human volunteers: Use of replicate design approach. Biopharmaceutics & Drug Disposition. 25(9). 367–372. 8 indexed citations
18.
Najib, Naji M., et al.. (2003). Pharmacokinetics and bioequivalence evaluation of two simvastatin 40 mg tablets (Simvast & Zocor) in healthy human volunteers. Biopharmaceutics & Drug Disposition. 24(5). 183–189. 36 indexed citations
19.
Najib, Naji M., et al.. (2002). Bioequivalence evaluation of two brands of gliclazide 80 mg tablets (Glyzide® & Diamicron®) — in healthy human volunteers. Biopharmaceutics & Drug Disposition. 23(5). 197–202. 16 indexed citations
20.
Welage, Lynda S., Nasir Idkaidek, Yayoi Hayashi, et al.. (2001). Human Jejunal Permeability of Two Polar Drugs: Cimetidine and Ranitidine. Pharmaceutical Research. 18(6). 742–744. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arzu Selen Breakdown of academic impact, for papers by André J. Jackson Breakdown of academic impact, for papers by KD Tripathi Breakdown of academic impact, for papers by Hwi‐yeol Yun Breakdown of academic impact, for papers by Noriyuki Namiki Breakdown of academic impact, for papers by Cristina Helena dos Reis Serra Breakdown of academic impact, for papers by W. Tetzloff Breakdown of academic impact, for papers by Oliver Yoa‐Pu Hu Breakdown of academic impact, for papers by H Laufen Breakdown of academic impact, for papers by Quan Zhou
Rankless by CCL
2026